Page last updated: 2024-08-18

morpholine and Agnogenic Myeloid Metaplasia

morpholine has been researched along with Agnogenic Myeloid Metaplasia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bonham, CA; Chenevert, TL; Heist, K; Jang, Y; Luker, GD; McDonald, L; Palagama, DSW; Ross, BD; Van Dort, ME; Zhang, EZ	1

Other Studies

1 other study(ies) available for morpholine and Agnogenic Myeloid Metaplasia

Article	Year
Structural effects of morpholine replacement in ZSTK474 on Class I PI3K isoform inhibition: Development of novel MEK/PI3K bifunctional inhibitors. European journal of medicinal chemistry, 2022, Feb-05, Volume: 229 Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Molecular Docking Simulation; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Primary Myelofibrosis; Protein Isoforms; Structure-Activity Relationship; Triazines	2022

Article

Year

Structural effects of morpholine replacement in ZSTK474 on Class I PI3K isoform inhibition: Development of novel MEK/PI3K bifunctional inhibitors.

European journal of medicinal chemistry, 2022, Feb-05, Volume: 229

Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase Kinases; Molecular Docking Simulation; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Primary Myelofibrosis; Protein Isoforms; Structure-Activity Relationship; Triazines

2022